ArticleSurgical endoscopy2026
Multimodal models based on radiomics and deep learning in the classification of gastric stromal tumors and gastric leiomyomas.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo establish and validate a multimodal model based on radiomics and deep learning for classifying gastric stromal tumors (GSTs) and gastric leiomyomas (GLMs).
methodsThe study collected clinical case data of 200 patients (137 GSTs and 63 GLMs) hospitalized for gastric submucosal tumors at the First Affiliated Hospital of Soochow University. The collected data included white light endoscopy, ultrasound endoscopic images, computed tomography (CT) images, records of endoscopic intervention, and pathological results. The patients were randomly divided into a training set (134 cases) and a validation set (66 cases) at a ratio of 7:3. A radiomics model was constructed by extracting radiomic features from three-dimensional CT images using XGBoost algorithm, while a deep learning model was developed based on convolutional neural network to extract deep features. Finally, clinical features and the predictions from the models were integrated to establish a multimodal model based on XGBoost algorithm. To enhance model visualization, variable importance ranking and local interpretable visualization were used. Area under the curve (AUC), sensitivity, specificity, false-negative rate (FNR), decision curve analysis net benefit, calibration, and tenfold stratified cross-validation stability assessed model performance.
resultsIn the multimodal model for the classification of GSTs and GLMs, the prediction of the deep learning model was the most important variable, followed by tumor echo homogeneity, age, the prediction of the radiomics model, and major axis of tumor. The multimodal model achieved excellent AUCs (0.927 in the training set, 0.882 in the validation set), outperforming both radiomics and deep learning models. It exhibited favorable calibration, minimal overfitting, a low FNR, and stable performance via tenfold cross-validation.
conclusionBased on the integration of clinical tabular data, radiomics, and deep learning features, the multimodal model could classify GSTs and GLMs, whose performance was better than the single modalities.
Indexed as
Identifiers
42257953What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.